Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: improved long-term survival

被引：1
|
作者：
Tubben, Alwin [1 ,2 ]
Nienhuis, Hans L. A. [2 ,3 ]
van der Meer, Peter [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Dept Cardiol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Amyloidosis Ctr Expertise, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1002/ejhf.3053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2065 / 2066
页数：2
相关论文
共 50 条
  • [11] Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy
    Kuyama, Naoto
    Izumiya, Yasuhiro
    Takashio, Seiji
    Usuku, Hiroki
    Tabira, Akihisa
    Oguni, Tetsuya
    Yamamoto, Masahiro
    Hirakawa, Kyoko
    Ishii, Masanobu
    Tabata, Noriaki
    Hoshiyama, Tadashi
    Kanazawa, Hisanori
    Hanatani, Shinsuke
    Kidoh, Masafumi
    Oda, Seitaro
    Matsuzawa, Yasushi
    Yamamoto, Eiichiro
    Hirai, Toshinori
    Ueda, Mitsuharu
    Tsujita, Kenichi
    CIRCULATION JOURNAL, 2025, 89 (04) : 421 - 431
  • [12] Long-term Treatment with Inotersen for Amyloid Transthyretin Amyloidosis Cardiomyopathy
    Dasgupta, Noel
    Benson, Merrill
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S59 - S59
  • [13] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Li, Benjamin
    Alvir, Jose
    Stewart, Michelle
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 535 - 540
  • [14] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Benjamin Li
    Jose Alvir
    Michelle Stewart
    Cardiology and Therapy, 2020, 9 : 535 - 540
  • [15] Long-term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction
    Drachman, Brian
    Damy, Thibaud
    Hanna, Mazen
    Wang, Ronnie
    Angeli, Franca S.
    Garcia-Pavia, Pablo
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (09) : 2038 - 2046
  • [16] Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
    Okamoto, Nao
    Kubo, Toru
    Nakashima, Yasuteru
    Ochi, Yuri
    Takahashi, Asa
    Baba, Yuichi
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kitaoka, Hiroaki
    INTERNAL MEDICINE, 2020, 59 (03) : 339 - 343
  • [17] Transthyretin amyloidosis cardiomyopathy disease staging systems for patients treated with tafamidis therapy
    Shahi, Karan
    Miller, Robert J. H.
    Dykstra, Steven
    Feng, Yuanchao
    Howlett, Jonathan G.
    Kassam, Shireen
    Veenhuyzen, Jan
    White, James A.
    Zepeda, Victor Jimenez
    Fine, Nowell M.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S88 - S89
  • [18] TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY DISEASE STAGING SYSTEMS FOR PATIENTS TREATED WITH TAFAMIDIS THERAPY
    Shahi, Karan
    Miller, Robert J. H.
    Dykstra, Steven
    Feng, Yuanchao
    Howlett, Jonathan G.
    Kassam, Shireen
    Veenhuyzen, Jan
    White, James
    Fine, Nowell Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 686 - 686
  • [19] Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy
    Elliott, P.
    Drachman, B. M.
    Gottlieb, S. S.
    Hoffman, J. E.
    Hummel, S. L.
    Lenihan, D. J.
    Ebede, B.
    Gundapaneni, B.
    Schwartz, J. H.
    Sultan, M. B.
    Shah, S. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 645 - 645
  • [20] Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
    Grogan, Martha
    Davis, Margot K.
    Crespo-Leiro, Maria G.
    Sultan, Marla B.
    Gundapaneni, Balarama
    Angeli, Franca Stedile
    Hanna, Mazen
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (03) : 612 - 615
12345